The Next-Generation Sequencing (NGS) services market is booming, projected to reach \$10.47 billion by 2025, with a CAGR of 13.43%. Driven by personalized medicine, genetic screening, and drug discovery, this report analyzes market trends, key players (Illumina, Thermo Fisher, Qiagen), and regional growth forecasts (North America, Europe, Asia-Pacific).
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.